Two competing infertility treatments—In Vitro Fertilization (IVF) and Restorative Reproductive Medicine (RRM)—are drawing Congressional debate amid differing medical philosophies and political pressures.
On Capitol Hill this week, representatives of IVF providers and advocates of RRM held separate briefings to promote their approaches to infertility care. IVF, a widely used procedure, involves fertilizing eggs with sperm in a lab before transferring embryos to the uterus.
It has helped bring about roughly 8 million babies in the U.S. RRM, by contrast, uses a range of less invasive methods such as medication, lifestyle modifications, cycle tracking, and surgery to treat underlying causes of infertility like endometriosis. However, RRM is not formally recognized as a medical specialty in the United States and lacks the extensive research backing that IVF has.
The American Society for Reproductive Medicine (ASRM), representing IVF providers, has criticized RRM as repackaging existing fertility treatments without robust evidence. At their briefing, ASRM panelists, including congressional staffers supporting IVF, warned that promoting RRM as an alternative could divert funding from IVF programs and jeopardize insurance coverage.
Conversely, supporters of RRM emphasize personal success stories and a patient-centered approach that focuses on diagnosing and addressing root causes rather than relying solely on laboratory fertilization. Several patients shared experiences of unsuccessful IVF attempts followed by pregnancy with RRM care.
The debate reflects broader cultural and political dynamics. Some conservative and anti-abortion groups back RRM, viewing IVF as ethically problematic. The “Make America Healthy Again” movement also promotes RRM, critiquing the pharmaceutical industry’s influence on reproductive medicine. These tensions have complicated the White House’s efforts to expand IVF access, as policy discussions now include these alternative treatments.
In response, the ASRM has released statements labeling RRM as “misleading” and continues to oppose any policies that limit IVF access. Meanwhile, the International Institute for Restorative Reproductive Medicine calls for collaboration to better serve patients and clarifies that their intent is not to oppose IVF but to increase awareness of their care approach.
This ongoing dispute highlights a crossroads in infertility treatment policy, balancing established medical practices, patient preferences, political ideologies, and ethical considerations.
YOU MAY ALSO LIKE
